Detalhe da pesquisa
1.
Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.
J Pathol
; 262(2): 129-136, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013631
2.
Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic Leiomyosarcomas.
Mod Pathol
; 37(5): 100474, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508521
3.
The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial Carcinoma.
Mod Pathol
; 36(9): 100234, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268062
4.
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.
Mod Pathol
; 36(4): 100084, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788080
5.
Landscape of chromatin remodeling gene alterations in endometrial carcinoma.
Gynecol Oncol
; 172: 54-64, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958196
6.
TERT promoter mutations and gene amplification in endometrial cancer.
Gynecol Oncol
; 179: 16-23, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890416
7.
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma.
Gynecol Oncol
; 174: 262-272, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37245486
8.
Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.
Mod Pathol
; 35(2): 274-282, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650187
9.
ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing.
Mod Pathol
; 35(7): 895-902, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963694
10.
Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
Mod Pathol
; 35(11): 1684-1694, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138078
11.
Genomic landscape of endometrial carcinomas of no specific molecular profile.
Mod Pathol
; 35(9): 1269-1278, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365770
12.
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
Mod Pathol
; 35(1): 117-127, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561551
13.
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma.
Mod Pathol
; 34(2): 490-501, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801341
14.
Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Mod Pathol
; 34(5): 1008-1016, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077922
15.
Uterine mesenchymal tumours: recent advances.
Histopathology
; 76(1): 64-75, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31846533
16.
DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Mod Pathol
; 32(10): 1447-1459, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186531
17.
Chorangiomatosis: Evaluation of a placental vascular lesion and related clinical effects.
Fetal Pediatr Pathol
; 33(5-6): 331-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25406659
18.
Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications.
Cancer Discov
; 13(11): 2356-2369, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651310
19.
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
Clin Cancer Res
; 29(22): 4660-4668, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643132
20.
Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology.
J Mol Diagn
; 25(9): 634-645, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330049